{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:21:23Z","timestamp":1779294083363,"version":"3.51.4"},"reference-count":36,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Objective: Coronavirus disease 2019 (COVID-19) is the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute respiratory distress and preterm delivery are the two major complications induced by SARS-CoV-2 infection during pregnancy. In the presence of dyspnea, the use of systemic corticosteroids was recommended in pregnant and non-pregnant groups. Our primary aim was to investigate the effect of early-onset steroid treatment on mortality and adverse effects in pregnant women with COVID-19. Our secondary aim was to investigate the effect of steroid treatment on the length of hospital stay and intensive care unit (ICU) stay, and duration of treatment. The study also investigated infection, preterm birth, and ideal body weight (lbw) in newborns. Methods: In this retrospective study, 253 patients were divided into three groups according to steroid administration. In Group 1 patients (n:112), treatment was started at the time of hospitalization. In Group 2 patients (n:90), treatment was started at least 24 h after hospitalization. Group 3 consisted of patients (n:51) who did not receive steroid treatment. Methylprednisolone (32 mg\/day) was given to pregnant patients with a gestational age below 24 weeks or above 34 weeks, and dexametazone (6 mg\/day) was given in four doses followed by 32 mg\/day methylprednisolone for the others (whose baby was at a gestational age of 24 weeks and above but less than 34 weeks). Result: The hospital stay, ICU stay, and steroid administration time were significantly lower in the Group 1 when compared to the others (p &lt; 0.05). The steroid treatment requirement was 4.4 days in Group 1 and 5.7 days in Group 2 (p &lt; 0.05). While no death was observed in Group 1, one patient died in Group 2 and three patients died in Group 3. There was no difference between the groups in terms of complications, including preterm labor. Conclusions: No death was also observed with early-onset treatment. Early-onset treatment may be beneficial for fewer hospitalizations, fewer ICU stays, and less mechanical ventilation requirement in pregnant women with COVID-19. In addition, with early treatment, the total number of steroid administration days was reduced, which is important in terms of reducing the risk of side effects.<\/jats:p>","DOI":"10.3390\/v16091453","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T06:31:40Z","timestamp":1726122700000},"page":"1453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the Effect of Early-Onset Steroid Treatment in the COVID-19-Positive Pregnant Women on Pregnancy Outcomes"],"prefix":"10.3390","volume":"16","author":[{"given":"Neval","family":"Elgormus","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulhalim","family":"Senyigit","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Okuyan","sequence":"additional","affiliation":[{"name":"Department of Child Health and Diseases, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9807-8257","authenticated-orcid":false,"given":"Fatma","family":"Bozkurt","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya Sivri","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1347-8498","authenticated-orcid":false,"given":"Hafize","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"WAPM (World Association of Perinatal Medicine) Working Group on COVID-19 (2021). Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet. Gynecol., 57, 232\u2013241. Correction in Ultrasound Obstet. Gynecol. 2021, 58, 496.","DOI":"10.1002\/uog.23107"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.ajogmf.2020.100107","article-title":"Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis","volume":"2","author":"Khalil","year":"2020","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jannasz, I., Pruc, M., Rahnama-Hezavah, M., Targowski, T., Olszewski, R., Feduniw, S., Petryka, K., and Szarpak, L. (2023). The Impact of COVID-19 on Carotid-Femoral Pulse Wave Velocity: A Systematic Review and Meta-Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175747"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2021). Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_6","unstructured":"(2020). Country & Technical Guidance\u2014Coronavirus Disease (COVID-19), World Health Organization. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance."},{"key":"ref_7","unstructured":"Royal College of Obstetricians and Gynaecologits (2021, March 04). Coronavirus \u0130nfection in Pregnancy. Available online: https:\/\/www.rcog.org.uk\/guidance\/coronavirus-covid-19-pregnancy-and-women-s-health\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/JMDH.S301255","article-title":"Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence","volume":"14","author":"Sserwanja","year":"2021","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/AOG.0000000000004103","article-title":"Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)","volume":"136","author":"Saad","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_10","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","unstructured":"The American College of Obstetricians and Gynaecologists (2021, March 04). Antenatal Corticosteroid Therapy for Fetal Maturation. Available online: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/08\/antenatal-corticosteroid-therapy-for-fetalmaturation."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/0004867420961472","article-title":"Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19","volume":"55","author":"Pantelis","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/jog.15205","article-title":"Incidence of gestational diabetes mellitus before and after the COV\u0130D-19 lockdown: A retrospective cohort study","volume":"48","author":"Torella","year":"2022","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"108841","DOI":"10.1016\/j.neuropharm.2021.108841","article-title":"SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants","volume":"201","author":"Figueiredo","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ijgo.13165","article-title":"Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia","volume":"150","author":"Wu","year":"2020","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/uog.22006","article-title":"Novel coronavirus infection and pregnancy","volume":"55","author":"Yang","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics (2016). Practice Bulletin No. 171: Management of Preterm Labor. Obstet. Gynecol., 128, e155\u2013e164.","DOI":"10.1097\/AOG.0000000000001711"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijgo.13146","article-title":"Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection","volume":"149","author":"Chen","year":"2020","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8870129","DOI":"10.1155\/2021\/8870129","article-title":"Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis","volume":"2021","author":"Karimi","year":"2021","journal-title":"J. Pregnancy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1080\/14767058.2020.1806817","article-title":"COVID-19 and maternal, fetal and neonatal mortality: A systematic review","volume":"355","author":"Hessami","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijgo.13726","article-title":"Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics","volume":"154","author":"Riemma","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/uog.23116","article-title":"Pregnancy and COVID-19: Pharmacologic considerations","volume":"57","author":"Ashraf","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_23","unstructured":"COVID-19 Treatment Guidelines Panel (2021). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines, National Institutes of Health (US)."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Vassiliou, A.G., Kotanidou, A., Dimopoulou, I., and Orfanos, S.E. (2020). Endothelial Damage in Acute Respiratory Distress Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228793"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"bqaa127","DOI":"10.1210\/endocr\/bqaa127","article-title":"Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes","volume":"161","author":"Klein","year":"2020","journal-title":"Endocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00134-015-4095-4","article-title":"Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients\u2019 data from four randomized trials and trial-level meta-analysis of the updated literature","volume":"42","author":"Meduri","year":"2016","journal-title":"Intensive Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.placenta.2005.12.010","article-title":"Metabolism of synthetic steroids by the human placenta","volume":"28","author":"Murphy","year":"2007","journal-title":"Placenta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103619","DOI":"10.1016\/j.jri.2022.103619","article-title":"Adverse effects of prenatal dexamethasone exposure on fetal development","volume":"151","author":"Wang","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.705336","article-title":"Prenatal exposure to prednisone in humans and animals retards intrauterine growth","volume":"202","author":"Reinisch","year":"1978","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9378(77)90215-0","article-title":"Fetal growth retardation associated with maternal administration of immunosuppressive drugs","volume":"128","author":"Scott","year":"1977","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-94-5-667","article-title":"Systemic lupus erythematosus in pregnancy","volume":"94","author":"Fine","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"ref_35","first-page":"243","article-title":"Single-dose glucocorticoid for prevention of respiratory distress syndrome","volume":"2","author":"Csaba","year":"1977","journal-title":"Lancet"},{"key":"ref_36","unstructured":"University of Oxford (2021, March 04). The Recovery Trial. Available online: https:\/\/www.recoverytrial.net\/."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/9\/1453\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:54:38Z","timestamp":1760111678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/9\/1453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["v16091453"],"URL":"https:\/\/doi.org\/10.3390\/v16091453","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}